Humana (HUM) DIvidends Date & History

Key Takeaways

• Humana Inc. (HUM) pays a quarterly dividend of $0.885 per share, equating to an annualized dividend of $3.54 per share and a dividend yield of approximately 1.4%, depending on the prevailing stock price.
• The company has maintained a 15-year dividend growth streak, consistently raising its payout every year since initiating its modern dividend program in 2011, though the quarterly rate has remained unchanged since 2023.
• With a payout ratio between roughly 20% and 35% of earnings, Humana's dividend is well covered, leaving ample room for reinvestment and signaling strong sustainability.
• Humana's yield is modest compared to larger managed-care peers such as UNH and ELV, making the stock more appealing for dividend growth and total-return investors than for pure income seekers.
• The next dividend payment date is July 31, 2026, with the most recent ex-dividend date having passed on June 26, 2026.

Dividend Overview

Humana Inc., one of the largest health insurance providers in the United States and a dominant player in the Medicare Advantage market, pays a quarterly cash dividend of $0.885 per share. On an annualized basis, this translates to $3.54 per share. At recent trading levels, the dividend yield hovers around 1.4%, though this figure fluctuates with movements in the company's stock price. Humana is best described as a dividend growth stock with a modest current yield — it is not a high-yield name, but its decade-and-a-half track record of annual increases underscores management's commitment to returning capital to shareholders. The dividend is paid every three months, aligning with the standard quarterly cadence common among U.S. large-cap companies. For the most recent cycle, the ex-dividend date was June 26, 2026, and the payable date is July 31, 2026.

Dividend History and Growth

Humana has paid dividends consistently for decades, but its modern dividend growth story began in earnest in 2011. Since that year, the company has increased its dividend every single year — a 15-year streak that places it among the more dependable dividend payers in the healthcare sector. The quarterly payout rose from $0.25 per share in 2011 to $0.625 by 2020, then accelerated to $0.70 in 2021, $0.7875 in 2022, and finally $0.885 in 2023. Notably, the quarterly rate has stayed at $0.885 since 2023, meaning the company's most recent annual increases have effectively paused. This pause reflects a period in which Humana faced margin pressure from rising medical costs and regulatory headwinds in its Medicare Advantage business. Despite the recent plateau, the long-term trajectory remains positive: the dividend has more than tripled over the past decade, reflecting the company's earnings growth and free cash flow generation. Dividend growth investors who prioritize consistency over maximum current yield may find this history compelling.

Dividend Sustainability and Payout Ratio

Humana's dividend appears highly sustainable based on standard coverage metrics. The dividend payout ratio — the percentage of earnings paid out as dividends — stands in a conservative range, with various data providers estimating it between roughly 20% and 35%, depending on whether calculations use GAAP (Generally Accepted Accounting Principles) earnings or adjusted earnings per share (EPS). A payout ratio in this range is well below the threshold that typically raises concerns among dividend analysts, leaving the company with substantial retained earnings for reinvestment, debt reduction, and share buybacks. Free cash flow coverage is similarly healthy: Humana's cash dividend payout ratio is approximately 33%, meaning only about one-third of the company's free cash flow is directed toward dividend payments. While Humana carries debt on its balance sheet — typical for a large managed-care organization — its financial profile remains stable, and the dividend does not appear to be at risk. That said, investors should monitor Medicare Advantage regulatory developments and medical cost trends, which can affect Humana's profitability more acutely than some of its more diversified peers.

Dividend Compared to Industry Peers

When measured against other large-cap companies in the managed-care and health insurance industry, Humana's dividend yield sits on the lower end of the spectrum. UNH (UnitedHealth Group) offers a yield above 2%, while ELV (Elevance Health) and CI (The Cigna Group) each yield between roughly 1.6% and 2.1%. CVS (CVS Health) stands as an outlier with a yield well above 4%, though that reflects company-specific pressures on its stock price rather than aggressive dividend policy. Meanwhile, competitors such as CNC (Centene) and MOH (Molina Healthcare) pay no dividend at all. Within this context, Humana occupies a middle ground: it delivers a reliable, growing dividend that is lower-yielding than its largest dividend-paying peers but more established than the non-payers in the group. For investors comparing the healthcare managed-care space, Humana's dividend profile is best suited for those willing to trade a higher current yield for exposure to a pure-play Medicare Advantage franchise with a long history of payout growth.

AI Screener

Tickeron's AI Screener is an AI-powered stock and ETF discovery platform designed to help traders and investors filter the market with precision and efficiency. The tool enables users to scan thousands of equities and exchange-traded funds using customizable criteria that include industry classification, market capitalization, technical indicators, price patterns, volatility metrics, and AI-driven trading signals. For dividend-focused investors, the AI Screener can surface income-generating stocks, track consistent dividend payers, and identify breakout candidates aligned with specific investment strategies. Whether you are searching for high-yield opportunities, dividend growth stocks, or sector-specific plays in the healthcare space, the AI Screener streamlines what would otherwise be a time-intensive manual process — helping you uncover actionable market opportunities faster.

Is This Stock Attractive for Dividend Investors?

Humana is likely to appeal most to dividend growth investors and long-term total-return investors rather than to those seeking high current income. With a yield of approximately 1.4%, the stock does not compete with high-yielding sectors such as utilities, real estate investment trusts (REITs), or telecommunications. However, Humana's 15-year track record of annual dividend increases, combined with a low payout ratio, suggests that dividend growth can resume once earnings headwinds subside. The company operates in a fundamentally defensive industry — healthcare — which provides a degree of resilience across economic cycles. For conservative income investors, the modest yield may be a drawback; for those prioritizing dividend reliability, growth potential, and exposure to the Medicare Advantage theme, Humana represents a balanced candidate worth monitoring. The key risk to watch is regulatory and reimbursement pressure in the Medicare Advantage market, which could weigh on earnings growth and, by extension, the pace of future dividend increases.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations